Deutsch English Français

Contact

EP3471734

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP3471734

EP3471734 - SOLID STATE FORMS OF IXAZOMIB CITRATE [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 24.09.2021 Database last updated on 01.04.2026
Former	The patent has been granted Status updated on 16.10.2020
Former	Grant of patent is intended Status updated on 07.06.2020
Former	Request for examination was made Status updated on 22.03.2019
Former	The international publication has been made Status updated on 29.12.2017
Former	unknown Status updated on 25.07.2017
Most recent event Tooltip	13.09.2024	Lapse of the patent in a contracting state New state(s): MT	published on 16.10.2024 [2024/42]
Applicant(s)	For all designated states Teva Pharmaceuticals International GmbH Schlüsselstrasse 12 8645 Jona / CH
	[2019/17]
Inventor(s)	01 / VALIK, Martin U Trznice 5 747 05 Male Hostice / CZ
	02 / GABRIEL, Roman Urxova 7 77900 Olomouc / CZ
	03 / VRASPIR, Pavel Dukelska 2 795 01 Rymarov / CZ
	04 / LUKAS, David Zdemyslice 193 33601 Blovice / CZ
	[2019/17]
Representative(s)	D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB
	[N/P]
Former [2019/17]	D Young & Co LLP 120 Holborn London EC1N 2DY / GB
Application number, filing date	17739381.6	08.06.2017
	[2019/17]
	WO2017US36482
Priority number, date	US201662352787P	21.06.2016 Original published format: US 201662352787 P
	US201662438073P	22.12.2016 Original published format: US 201662438073 P
	[2019/17]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2017222819
	Date:	28.12.2017
	Language:	EN
	[2017/52]
	Type:	A2 Application without search report
	No.:	EP3471734
	Date:	24.04.2019
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 28.12.2017 takes the place of the publication of the European patent application.
	[2019/17]
	Type:	B1 Patent specification
	No.:	EP3471734
	Date:	18.11.2020
	Language:	EN
	[2020/47]
Search report(s)	International search report - published on:	EP	19.04.2018
Classification	IPC:	A61K31/69, C07F5/04, A61P35/00	[2019/17]
	CPC:	C07F5/025 (EP,US); A61K31/69 (EP); A61P35/00 (EP); C07B2200/13 (EP,US)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/17]
Extension states	BA	Not yet paid
	ME	Not yet paid
Validation states	MA	Not yet paid
	MD	Not yet paid
Title	German:	FESTE FORMEN VON IXAZOMIBCITRAT	[2019/17]
	English:	SOLID STATE FORMS OF IXAZOMIB CITRATE	[2019/17]
	French:	FORMES À L'ÉTAT SOLIDE DE CITRATE D'IXAZOMIB	[2019/17]
Entry into regional phase	21.12.2018	National basic fee paid
	21.12.2018	Designation fee(s) paid
	21.12.2018	Examination fee paid
Examination procedure	21.12.2018	Examination requested [2019/17]
	21.12.2018	Date on which the examining division has become responsible
	25.07.2019	Amendment by applicant (claims and/or description)
	08.06.2020	Communication of intention to grant the patent
	06.10.2020	Fee for grant paid
	06.10.2020	Fee for publishing/printing paid
	06.10.2020	Receipt of the translation of the claim(s)
Divisional application(s)	EP20207885.3 / EP3798224
	EP25164570.1
Opposition(s)	19.08.2021	No opposition filed within time limit [2021/43]
Fees paid	Renewal fee
	25.06.2019	Renewal fee patent year 03
	31.03.2020	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	08.06.2017
	AL	18.11.2020
	AT	18.11.2020
	CY	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	MC	18.11.2020
	MK	18.11.2020
	MT	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
	IE	08.06.2021
	LU	08.06.2021
	BE	30.06.2021
	[2024/42]
Former [2024/22]	HU	08.06.2017
	AL	18.11.2020
	AT	18.11.2020
	CY	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	MC	18.11.2020
	MK	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
	IE	08.06.2021
	LU	08.06.2021
	BE	30.06.2021
Former [2023/33]	HU	08.06.2017
	AL	18.11.2020
	AT	18.11.2020
	CY	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	MC	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
	IE	08.06.2021
	LU	08.06.2021
	BE	30.06.2021
Former [2023/30]	AL	18.11.2020
	AT	18.11.2020
	CY	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	MC	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
	IE	08.06.2021
	LU	08.06.2021
	BE	30.06.2021
Former [2022/34]	AL	18.11.2020
	AT	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	MC	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
	IE	08.06.2021
	LU	08.06.2021
	BE	30.06.2021
Former [2022/23]	AL	18.11.2020
	AT	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	MC	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
	IE	08.06.2021
	LU	08.06.2021
Former [2022/21]	AL	18.11.2020
	AT	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	MC	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	PT	18.03.2021
	IE	08.06.2021
	LU	08.06.2021
Former [2022/18]	AL	18.11.2020
	AT	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	MC	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	PT	18.03.2021
	LU	08.06.2021
Former [2022/10]	AL	18.11.2020
	AT	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	MC	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	PT	18.03.2021
Former [2022/08]	AL	18.11.2020
	AT	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	MC	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
Former [2021/50]	AL	18.11.2020
	AT	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SI	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
Former [2021/45]	AL	18.11.2020
	AT	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
Former [2021/37]	AT	18.11.2020
	DK	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
Former [2021/36]	AT	18.11.2020
	EE	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
Former [2021/35]	AT	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	PL	18.11.2020
	RO	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SK	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
Former [2021/33]	AT	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LT	18.11.2020
	LV	18.11.2020
	PL	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
Former [2021/32]	AT	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LV	18.11.2020
	PL	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	SM	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
Former [2021/28]	AT	18.11.2020
	FI	18.11.2020
	HR	18.11.2020
	LV	18.11.2020
	PL	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
Former [2021/25]	AT	18.11.2020
	FI	18.11.2020
	LV	18.11.2020
	PL	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	IS	18.03.2021
	PT	18.03.2021
Former [2021/23]	AT	18.11.2020
	FI	18.11.2020
	LV	18.11.2020
	RS	18.11.2020
	SE	18.11.2020
	BG	18.02.2021
	NO	18.02.2021
	GR	19.02.2021
	PT	18.03.2021
Former [2021/22]	FI	18.11.2020
	RS	18.11.2020
	NO	18.02.2021
	PT	18.03.2021
Former [2021/21]	FI	18.11.2020
	PT	18.03.2021
Former [2021/20]	FI	18.11.2020
Cited in	International search	[AD] WO2009154737 (MILLENNIUM PHARM INC et al.)
		[ADP] WO2016155684 (ZENTIVA KS et al.)
	by applicant	WO2009154737
		WO2016155684
		WO2016165677
		WO2017046815
		US8859504

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.